CHIWOS

BC-CfE Study Finds a Majority of HIV-Positive Women Who Use Injection Drugs Face Legal Obligation to Disclose HIV Status to Sexual Partners

Vancouver, BC [July 17, 2015] A new British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) study finds 44 per cent of participants within a research cohort of people who use injection drugs living with HIV in Vancouver would be legally obligated to disclose their HIV status to their sexual partners. Within the study, 65 per cent of male participants compared with only 45 percent of female participants satisfied the Supreme Court of Canada’s legal test for HIV non-disclosure, based on the October 2012 ruling in R v. Mabior.

BC-CfE Study Finds a Majority of HIV-Positive Women Who Use Injection Drugs Face Legal Obligation to Disclose HIV Status to Sexual Partners Read More »

PhD student Kate Salters receives multiple awards for research on vulnerable woman living with HIV

FHS congratulates Doctoral student Kate Salters, who received awards from both the Soroptomist Foundation of Canada and CIHR to support her research that will improve the quality of women’s lives. Salters will receive $7,500 from the Soroptimist Foundation of Canada for her PhD research examining the social, physical, and environmental barriers to accessing sexual and

PhD student Kate Salters receives multiple awards for research on vulnerable woman living with HIV Read More »

Support base grows for advancing Treatment as Prevention as the global strategy

Vatican, Panama and formalized UNAIDS agreement add further momentum to saving lives, preventing infections and saving money Several recent international endorsements and agreements underline the growing universal acceptance of the made-in-BC Treatment as Prevention Strategy. Support from the Vatican, formalization of an agreement with the Joint United Nations Programme on HIV/AIDS (UNAIDS), and a Memorandum

Support base grows for advancing Treatment as Prevention as the global strategy Read More »

Aboriginal AIDS Awareness Week shines a light on HIV rates among indigenous people

VALERIE NICHOLSON REMEMBERS the room going silent the day she received her diagnosis. After the doctor told her she had HIV, she was sent to another room to receive her medication, a place that she recalls as “the most scary thing in my life”. And after the initial revelation, she didn’t absorb anything that followed.

Aboriginal AIDS Awareness Week shines a light on HIV rates among indigenous people Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below